Gestational Trophoblastic Disease-GTD
Gestational Trophoblastic Disease (GTD) encompasses a group of rare tumors arising from placental tissue.
It includes complete and partial molar pregnancies, invasive moles, and choriocarcinoma. GTD can cause abnormal vaginal bleeding, rapid uterine growth, and high hCG levels. Early detection is essential for effective treatment through surgery, chemotherapy, or close monitoring.
Causes and Risk Factors of Gestational Trophoblastic Disease
GTD results from abnormal fertilization events leading to abnormal placental tissue growth.
- Molar pregnancy: Complete or partial mole is the most common precursor.
- Age: Higher risk in women under 20 or over 35.
- History of GTD: Prior molar pregnancy increases risk of recurrence.
Symptoms and Clinical Features
GTD often presents with early warning signs.
- Abnormal vaginal bleeding
- Rapid uterine enlargement: Uterus grows faster than expected for gestational age
- Severe nausea and vomiting
- High hCG levels detected on blood tests
Treatment Strategies for Gestational Trophoblastic Disease
Treatment depends on disease type and extent.
- Surgical management: Evacuation of molar tissue via dilation and curettage or hysterectomy in selected cases.
- Chemotherapy: For invasive moles or choriocarcinoma to prevent metastasis.
- Follow-up monitoring of hCG levels to ensure complete remission.
Why Choose Us for Gestational Trophoblastic Disease
CureU Healthcare provides expert gynecologic oncology care, precise diagnostics, and close follow-up to ensure complete recovery and minimize recurrence.
Conclusion
Gestational Trophoblastic Disease is rare but highly treatable with early diagnosis. CureU Healthcare ensures comprehensive management and personalized patient care.
